← Eichor
Study identifier: NCT06662929 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Arabic PRO Measures for Head and Neck Cancer Radiotherapy.

Condition: Head and Neck Cancer · Head and Neck Neoplasms · Head and Neck Squamous Cell Carcinoma  ·  Sponsor: King Saud University

PhaseN/A
Planned participants125
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are: * To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients. * To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics. The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Abdullah M Alsoghier, PhD  ·  +966114677423  ·  aalsoghier@ksu.edu.sa

Saif A Aljabab, DABR  ·  saljabab@ksu.edu.sa

Always discuss trial participation with your own doctor first.

Locations (1)

King Saud University Medical CityRiyadh, Saudi ArabiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06662929